A Comprehensive Secondary Prevention Benchmark (2PBM) Score Identifying Differences in Secondary Prevention Care in Patients After Acute Coronary Syndrome

摘要

The objective of this study was to quantify secondary prevention care by creating a secondary prevention benchmark (2PBM) score for patients undergoing ambulatory cardiac rehabilitation (CR) after acute coronary syndrome (ACS). In this observational cohort study, 472 consecutive ACS patients who completed the ambulatory CR program between 2017 and 2019 were included. Benchmarks for secondary prevention medication and clinical and lifestyle targets were predefined and combined in the comprehensive 2PBM score with maximum 10 points. The association of patient characteristics and achievement rates of components and the 2PBM were assessed using multivariable logistic regression analysis. Patients were on average 62 ± 11 yr of age and predominantly male (n = 406; 86). The types of ACS were ST-elevation myocardial infarction (STEMI) in 241 patients (51) and non–ST-elevation myocardial infarction in 216 patients (46). Achievement rates for components of the 2PBM were 71 for medication, 35 for clinical benchmark, and 61 for lifestyle benchmark. Achievement of medication benchmark was associated with younger age (OR = 0.979: 95 CI, 0.959-0.996, P = .021), STEMI (OR = 2.05: 95 CI, 1.35-3.12, P = .001), and clinical benchmark (OR = 1.80: 95 CI, 1.15-2.88, P = .011). Overall ≥8 of 10 points were reached by 77 and complete 2PBM by 16, which was independently associated with STEMI (OR = 1.79: 95 CI, 1.06-3.08, P = .032). Benchmarking with 2PBM identifies gaps and achievements in secondary prevention care. ST-elevation myocardial infarction was associated with the highest 2PBM scores, suggesting best secondary prevention care in patients after ST-elevation myocardial infarction.